Evidence map›Paper›PMID 42376312›Full record

ArticleSaudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society

Mehdi Aminizade, Ghazal Ghochani, Kosar Esmaili, Amirhossein Hashemi, Amirhossein Valizadeh, Mohamad Sanei, Jaron C Sanchez, Seyed A Tabatabaei, Morteza Karimi, Mohammad Soleimani

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mehdi AminizadeEye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Ghazal GhochaniEye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Kosar EsmailiEye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Amirhossein HashemiEye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Amirhossein ValizadehEye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Mohamad SaneiEye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Jaron C SanchezDepartment of Ophthalmology, University of North Carolina, North Carolina, USA.
Seyed A TabatabaeiEye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Morteza KarimiEye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Mohammad SoleimaniDepartment of Ophthalmology, University of North Carolina, North Carolina, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis study evaluates the clinical characteristics, microbiological profile, and management strategies of

methodsThis retrospective study on culture-proven

resultsA total of 38 patients were included in the study, with 16 requiring inpatient management and 22 managed as outpatients. The mean duration from symptom onset to presentation was 28.62 (median = 4.0) days, and the mean infiltration size was 2.7 ± 1.0 mm. Contact lens (CL) use was the most common risk factor, identified in eight patients (21.1%). There were no significant differences in age, infiltration size, presenting visual acuity (logMAR), or admission duration between CL users and nonusers (

conclusion

Indexed as

Amikacincontact lensNocardia keratitis

Identifiers

PMID42376312
PMCPMC13313642

What Socratic holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.